Home
Technologies
Facilities
Awards
Publications
Patents
Research Group
Contact
More
Application of 3D printing technology for the development of dose adjustable geriatric and pediatric formulation of celecoxib
Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition modelling (FDM) 3D printer
Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction
Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer
Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen